Ridgecrest Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ridgecrest Wealth Partners's LLY Position: Q3 2026 in Review
Ridgecrest Wealth Partners increased its Eli Lilly (LLY) stake by 6.7% in Q3 2026, buying an estimated $69.6K and bringing the position to 943 shares worth $1.09M. The position accounts for 0.5% of the portfolio, ranked #37.
Ridgecrest Wealth Partners first reported a position in LLY in Q3 2021 and has held it in 21 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Ridgecrest Wealth Partners held 943 shares of Eli Lilly worth $1.09M as of Q3 2026.
- Ridgecrest Wealth Partners bought 59 Eli Lilly shares in Q3 2026, an estimated $69.6K.
- Eli Lilly made up 0.5% of Ridgecrest Wealth Partners's portfolio in Q3 2026, its #37 holding.
- Ridgecrest Wealth Partners first reported a position in Eli Lilly in Q3 2021 and has held it in 21 quarters since.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Ridgecrest Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.